Momentum indicators in the "xbi stock price forecast" reveal RSI levels approaching bullish thresholds, suggesting traders may see short-term entry opportunities. Among the 34 analysts covering BIIB stock, the consensus is a “Moderate Buy.” That’s based on 13 “Strong Buy” ratings, one “Moderate Buy,” and 20 “Holds.” For the most part, other analysts are on the same page. With 3 Buys and 1 Hold, the word on the Street is that TIL is a Strong Buy. The stock’s $20.10 trading price and $114 average price target together imply an upside of 467% for the coming year. (See TIL stock forecast ) Market sentiment around the "xbi stock price forecast" has improved as the SPDR S&P Biotech ETF rebounds from recent lows, supported by increased M&A activity in the biotech industry and strong Phase III trial results from component companies.
